Companies /Healthcare

Seattle Genetics, Inc.

NASDAQ: SGEN Biotechnology
$228.74
▲ $0.00 (+0.00%) today
Markets open · 9:56am ET

SGEN Coverage

Page 2
12:10pm ET
Health and Healthcare

Why This Successful Bladder Cancer Study May Not Be Enough

Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in Barcelona, Spain.

Chris Lange
11:00am ET
Health and Healthcare

Why Cascadian Therapeutics Shares Are Skyrocketing

Cascadian Therapeutics saw its shares absolutely skyrocket on Wednesday after it was announced that Seattle Genetics would be acquiring the company. This is far and away the top-performing stock in Wednesday’s session.

Chris Lange